Customer Endorsements

What our customers are saying:

This panel [Staph ID/R Blood Culture Panel] did exactly what MALDI cannot do. We’re pleased!

Reference Lab Microbiology Team Leader / Ohio

We love the Great Basin system. Easy to use, state of the art testing. Great business model. We can run tests in our small lab that we would otherwise not be able to run.

Laboratory Director / Massachusetts

The procedure is extremely easy….all techs on every shift can run this assay, compared to only a few with our previous method.

Hospital Microbiology Supervisor / Michigan

Your system is so easy to run and gives great results. I don’t understand how any lab would not adopt this system.

Laboratory Director / Idaho

I love this system. So easy to run and easy to adopt. We’ll use every test you have.

Hospital Laboratory Director / Wyoming

I don’t feel like I’m just a number with you guys!

Microbiology Lab Director / Florida

My techs were unanimous: the Great Basin tests were easier to use than our current platform.

Microbiology Lab Supervisor / Kansas

Learn more about how Great Basin’s sample-to-result system can help your hospital or lab make fast and accurate molecular diagnostics possible.

In the News

Great Basin and Rice University Announce Collaboration to Optimize the Design of SARS-CoV-2 Molecular Assays
August 25, 2020

Salt Lake City, Utah, and Houston, Texas – August 25, 2020 (PRWeb) – Great Basin Scientific, a [...]

Vela Diagnostics Submitting Novel Coronavirus Diagnostic Test to FDA for Emergency Use Authorization (UPDATE)
February 11, 2020

Singapore, February 11, 2020 (updated on February 21, 2020) – Vela Diagnostics has developed the [...]

Vela Diagnostics Announces Development of New Test Kit for Detection of Wuhan Coronavirus
January 31, 2020

Singapore, January 30, 2020 – Vela Diagnostics has announced the development of the ViroKeyTM SA201 2019-nCoV [...]

Vela Diagnostics Buys Great Basin Scientific
June 21, 2018

Adds 6 FDA Approved Products on a Medium Multiplexing Platform and Microbiology Know-how Enabling our [...]

Stool Bacterial Pathogens Panel Receives FDA Clearance; Commercial Rollout Begins Immediately
July 13, 2017

At clearance, Company has nearly $2.0 million of potential annual revenue in active or scheduled [...]

Data Demonstrating Efficacy of Stool Bacterial Pathogens Panel Presented at ASM Microbe 2017
June 1, 2017

Four posters describing the Company’s platform to be presented, including a third-party clinical study poster [...]

Bordetella Direct Test Receives FDA Clearance
April 3, 2017

Sample-to-result test for Bordetella pertussis, or whooping cough, receives clearance in fewer than 60 days from [...]

Great Basin Staph ID/R Blood Culture Panel Clinical Evaluation Published in Journal of Clinical Microbiology
February 15, 2017

Multicenter evaluation demonstrates Staph ID/R Blood Culture Panel’s efficacy in rapid identification of Staphylococci and [...]

View More